Niloofar Rahmani

Array ( [id] => 582033 [patent_doc_number] => 07452993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Fused ring heterocycle kinase modulators' [patent_app_type] => utility [patent_app_number] => 11/192318 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 44141 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452993.pdf [firstpage_image] =>[orig_patent_app_number] => 11192318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4867752 [patent_doc_number] => 20080146811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-19 [patent_title] => 'Compounds and Methods For Treatment of Thrombosis' [patent_app_type] => utility [patent_app_number] => 11/658121 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 32520 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20080146811.pdf [firstpage_image] =>[orig_patent_app_number] => 11658121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927946 [patent_doc_number] => 20080167309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Pharmaceutical Compounds' [patent_app_type] => utility [patent_app_number] => 11/572305 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48217 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167309.pdf [firstpage_image] =>[orig_patent_app_number] => 11572305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4887693 [patent_doc_number] => 20080262025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Processes for the Preparation of Zolpidem and its Hemitartrate' [patent_app_type] => utility [patent_app_number] => 11/572017 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3401 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262025.pdf [firstpage_image] =>[orig_patent_app_number] => 11572017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794286 [patent_doc_number] => 20060014967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Process for isolating of alpha-mangostin' [patent_app_type] => utility [patent_app_number] => 11/181289 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1873 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014967.pdf [firstpage_image] =>[orig_patent_app_number] => 11181289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 574677 [patent_doc_number] => 07459451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-02 [patent_title] => 'Pyrazolopyridine derivatives' [patent_app_type] => utility [patent_app_number] => 11/171320 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51150 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/459/07459451.pdf [firstpage_image] =>[orig_patent_app_number] => 11171320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7070191 [patent_doc_number] => 20050245576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Substituted pyrazoles' [patent_app_type] => utility [patent_app_number] => 11/174077 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57494 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245576.pdf [firstpage_image] =>[orig_patent_app_number] => 11174077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609791 [patent_doc_number] => 07151185 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Gas phase synthesis of methylene lactones using oxynitride catalyst' [patent_app_type] => utility [patent_app_number] => 11/168648 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4887 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151185.pdf [firstpage_image] =>[orig_patent_app_number] => 11168648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821296 [patent_doc_number] => 20060025609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Supercritical fluid phase synthesis of methylene lactones using oxynitride catlayst' [patent_app_type] => utility [patent_app_number] => 11/169102 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4986 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025609.pdf [firstpage_image] =>[orig_patent_app_number] => 11169102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 545309 [patent_doc_number] => 07166727 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-23 [patent_title] => 'Supercritical fluid phase synthesis of methylene lactones using novel grafted catalyst' [patent_app_type] => utility [patent_app_number] => 11/168647 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7103 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/166/07166727.pdf [firstpage_image] =>[orig_patent_app_number] => 11168647 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 557004 [patent_doc_number] => 07161014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Gas phase synthesis of methylene lactones using novel grafted catalyst' [patent_app_type] => utility [patent_app_number] => 11/169128 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6750 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/161/07161014.pdf [firstpage_image] =>[orig_patent_app_number] => 11169128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821297 [patent_doc_number] => 20060025610 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Liquid phase synthesis of methylene lactones using novel catalyst' [patent_app_type] => utility [patent_app_number] => 11/169127 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4825 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025610.pdf [firstpage_image] =>[orig_patent_app_number] => 11169127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 501831 [patent_doc_number] => 07205416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-04-17 [patent_title] => 'Liquid phase synthesis of methylene lactones using novel grafted catalyst' [patent_app_type] => utility [patent_app_number] => 11/168829 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4710 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/205/07205416.pdf [firstpage_image] =>[orig_patent_app_number] => 11168829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5361687 [patent_doc_number] => 20090036481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'Novel Azaindole Inhibitors of Mtp and Apob' [patent_app_type] => utility [patent_app_number] => 11/658596 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 23316 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20090036481.pdf [firstpage_image] =>[orig_patent_app_number] => 11658596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821291 [patent_doc_number] => 20060025604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Liquid phase synthesis of methylene lactones using oxnitride catalyst' [patent_app_type] => utility [patent_app_number] => 11/168626 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4242 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025604.pdf [firstpage_image] =>[orig_patent_app_number] => 11168626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821299 [patent_doc_number] => 20060025612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Gas phase synthesis of methylene lactones using novel catalyst' [patent_app_type] => utility [patent_app_number] => 11/169136 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4952 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025612.pdf [firstpage_image] =>[orig_patent_app_number] => 11169136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5821295 [patent_doc_number] => 20060025608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Supercritical fluid phase synthesis of methylene lactones using novel catalyst field of invention' [patent_app_type] => utility [patent_app_number] => 11/169033 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9543 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025608.pdf [firstpage_image] =>[orig_patent_app_number] => 11169033 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5178116 [patent_doc_number] => 20070179176 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Monohydrated sodium salt of s-tenatoprazole and the use thereof in therapy' [patent_app_type] => utility [patent_app_number] => 10/561844 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6129 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179176.pdf [firstpage_image] =>[orig_patent_app_number] => 10561844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016672 [patent_doc_number] => 20070259881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Substituted Imidazo Ring Systems and Methods' [patent_app_type] => utility [patent_app_number] => 11/570715 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61198 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259881.pdf [firstpage_image] =>[orig_patent_app_number] => 11570715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4508132 [patent_doc_number] => 07915281 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method' [patent_app_type] => utility [patent_app_number] => 11/570716 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44333 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915281.pdf [firstpage_image] =>[orig_patent_app_number] => 11570716 [rel_patent_id] =>[rel_patent_doc_number] =>)